Michele De Tursi

A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti et al. · Journal for ImmunoTherapy of Cancer · 2019 · 400 citations · Full text

Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

Alessio Cortellini, Marco Tucci, Vincenzo Adamo et al. · Journal for ImmunoTherapy of Cancer · 2020 · 250 citations · Full text

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study

Nick van Es, Marcello Di Nisio, Gabriela Cesarman et al. · Haematologica · 2017 · 224 citations · Full text

Prognosis, Pharmacotherapy, Cancer Patients +18

Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study

Alessio Cortellini, Sebastiano Buti, Daniele Santini et al. · The Oncologist · 2019 · 214 citations · Full text

Immunology, Immunoediting, Pathology +21

Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients

Antonio Marchetti, John F. Palma, Lara Felicioni et al. · Journal of Thoracic Oncology · 2015 · 175 citations · Full text